Compare PZZA & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PZZA | QDEL |
|---|---|---|
| Founded | 1984 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 1995 | 2022 |
| Metric | PZZA | QDEL |
|---|---|---|
| Price | $33.39 | $11.95 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 4 |
| Target Price | ★ $45.00 | $28.25 |
| AVG Volume (30 Days) | 1.1M | ★ 2.2M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 5.25% | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ 0.21 | N/A |
| Revenue | $2,068,421,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | N/A | $3.86 |
| P/E Ratio | $155.88 | ★ N/A |
| Revenue Growth | ★ 14.07 | N/A |
| 52 Week Low | $30.16 | $9.92 |
| 52 Week High | $55.74 | $35.58 |
| Indicator | PZZA | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 46.99 | 47.70 |
| Support Level | $33.30 | $10.39 |
| Resistance Level | $35.49 | $12.85 |
| Average True Range (ATR) | 1.80 | 0.95 |
| MACD | -0.08 | 0.34 |
| Stochastic Oscillator | 50.64 | 70.14 |
Papa John's International Inc operates and franchises pizza delivery and carryout restaurants and, in certain international markets, dine-in and delivery restaurants. It has four defined reportable segments: Domestic Company-owned restaurants, North America franchising, North America commissaries, and International. The company derives maximum revenue from North America commissaries segment. The North America commissaries segment consists of the operations of its regional dough production and product distribution centers in the United States and Canada and derives its revenues principally from the sale and distribution of food and paper products to Domestic Company-owned and franchised restaurants in the United States and Canada.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.